Kezar Life Sciences logo

Kezar Life Sciences share price today

(KZR)

Kezar Life Sciences share price is $6.56 & ₹558.90 as on 25 Dec 2024, 2.30 'hrs' IST

$6.56

0.12

(1.86%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Kezar Life Sciences share price in Dollar and Rupees. Guide to invest in Kezar Life Sciences from India. Also see the sentimental analysis on Indian investors investing in Kezar Life Sciences. Get details on the Indian mutual funds that are investing in Kezar Life Sciences. Get Analyst recommendations and forecasts along with all the Kezar Life Sciences's financials.

Kezar Life Sciences share price movements

  • Today's Low: $6.33
    Today's High: $6.56

    Day's Volatility :3.51%

  • 52 Weeks Low: $5.20
    52 Weeks High: $11.35

    52 Weeks Volatility :54.17%

Kezar Life Sciences Returns

PeriodKezar Life Sciences IncSector (Health Care)Index (Russel 2000)
3 Months
24.12%
-9.0%
0.0%
6 Months
3.42%
-4.6%
0.0%
1 Year
-32.19%
3.0%
0.0%
3 Years
-95.84%
0.0%
-21.1%

Kezar Life Sciences Key Statistics

in dollars & INR

Previous Close
$6.44
Open
$6.4
Today's High
$6.56
Today's Low
$6.33
Market Capitalization
$47.9M
Today's Volume
$12.7K
52 Week High
$11.35
52 Week Low
$5.202
Revenue TTM
$7.0M
EBITDA
$-98.5M
Earnings Per Share (EPS)
$-13.12
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-51.48%

How to invest in Kezar Life Sciences from India?

It is very easy for Indian residents to invest directly in Kezar Life Sciences from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Kezar Life Sciences stock in both Indian Rupees (INR) and US Dollars (USD). Search for Kezar Life Sciences or KZR on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Kezar Life Sciences or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Kezar Life Sciences shares which would translate to 0.130 fractional shares of Kezar Life Sciences as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Kezar Life Sciences, in just a few clicks!

Returns in Kezar Life Sciences for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Kezar Life Sciences investment value today

Current value as on today

₹70,077

Returns

₹29,923

(-29.92%)

Returns from Kezar Life Sciences Stock

₹32,161 (-32.16%)

Dollar Returns

₹2,239 (+2.24%)

Indian investors sentiment towards Kezar Life Sciences

43%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Kezar Life Sciences on INDmoney from India has grown in the last 30 days as on Dec 26, 2024. 43% more investors are searching Kezar Life Sciences in the last 30 days versus the previous period.

Global Institutional Holdings in Kezar Life Sciences

  • Suvretta Capital Management, LLC

    98.24%

  • Avidity Partners Management LP

    68.89%

  • Vanguard Group Inc

    37.57%

  • Sphera Funds Management Ltd.

    28.12%

  • Orbimed Advisors, LLC

    26.41%

  • Affinity Asset Advisors, LLC

    24.15%

Analyst Recommendation on Kezar Life Sciences

Buy

    60%Buy

    40%Hold

    0%Sell

Based on 10 Wall street analysts offering stock ratings for Kezar Life Sciences(by analysts ranked 0 to 5 stars)

Based on 10 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
4
4
4
Sell
0
0
0

Analyst Forecast on Kezar Life Sciences

What analysts predicted

Upside of 105.79%

Current:

$6.56

Target:

$13.50

Insights on Kezar Life Sciences

  • Price Movement

    In the last 3 years, KZR stock has moved down by -95.8%
  • KZR vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.2% return, outperforming this stock by 51.0%
  • KZR vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 121.0%
  • Price to Sales

    ForKZR every $1 of sales, investors are willing to pay $6.8, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.7 for every $1 of sales.

Kezar Life Sciences Technicals Summary

Sell

Neutral

Buy

Kezar Life Sciences is currently in a neutral trading position according to technical analysis indicators.

Kezar Life Sciences Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Kezar Life Sciences Inc
-11.71%
3.42%
-32.19%
-95.84%
-84.6%
Regeneron Pharmaceuticals, Inc.
-5.12%
-32.01%
-18.29%
12.56%
91.19%
Biontech Se
-3.72%
41.99%
6.11%
-55.22%
226.93%
Alnylam Pharmaceuticals, Inc.
-3.99%
-1.52%
23.75%
50.98%
112.09%
Vertex Pharmaceuticals Incorporated
-12.61%
-13.61%
0.03%
83.58%
86.41%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Kezar Life Sciences Inc
NA
NA
NA
-6.7
-0.51
-0.28
NA
25.77
Regeneron Pharmaceuticals, Inc.
17.67
17.67
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Kezar Life Sciences Inc
Buy
$47.9M
-84.6%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.5B
91.19%
17.67
33.61%
Biontech Se
Buy
$27.4B
226.93%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$31.4B
112.09%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$105.1B
86.41%
32.84
-4.51%

About Kezar Life Sciences

kezar life sciences, inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer in the united states. the company's lead product candidate is kzr-616, a selective immunoproteasome inhibitor that is in phase 2 clinical trials across five autoimmune indications, including lupus nephritis, autoimmune hemolytic anemia, immune thrombocytopenia, dermatomyositis, and polymyositis; and phase 1b/2 clinical trials in systemic lupus erythematosus and lupus nephritis. its preclinical products include kzr-616, a selective immunoproteasome inhibitor for the treatment of various autoimmune disease indications; and kzr-tbd for the treatment of oncology and autoimmunity. the company was founded in 2015 and is headquartered in south san francisco, california.
Organization
Kezar Life Sciences
Employees
58
CEO
Dr. Christopher J. Kirk Ph.D.
Industry
Health Technology

Management People of Kezar Life Sciences

NameTitle
Dr. Christopher J. Kirk Ph.D.
Co-Founder, CEO & Director
Mr. John Franklin Fowler
Co-Founder & Director
Dr. Jack Taunton Ph.D.
Co-Founder
Ms. Gitanjali Jain
Senior Vice President of Investor Relations & External Affairs
Mr. Mark Schiller
Chief Legal Officer
Mr. Joe Tedrick
Vice President of Human Resources
Dr. Neel K. Anand Ph.D.
Senior Vice President of Research & Drug Discovery
Mr. Zung To
Senior Vice President of Clinical Development
Ms. Pattie Chiang
Senior VP & Corporate Controller

Important FAQs about investing in Kezar Life Sciences from India :

What is Kezar Life Sciences share price today?

Kezar Life Sciences share price today stands at $6.56, Open: $6.40 ; Previous Close: $6.44 ; High: $6.56 ; Low: $6.33 ; 52 Week High: $11.35 ; 52 Week Low: $5.20. The stock opens at $6.40, after a previous close of $6.44. The stock reached a daily high of $6.56 and a low of $6.33, with a 52-week high of $11.35 and a 52-week low of $5.20.

Can Indians buy Kezar Life Sciences shares?

Yes, Indians can invest in the Kezar Life Sciences (KZR) from India.

With INDmoney, you can buy Kezar Life Sciences at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Kezar Life Sciences at zero transaction cost.

How can I buy Kezar Life Sciences shares from India?

It is very easy to buy Kezar Life Sciences from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Kezar Life Sciences be purchased?

Yes, you can buy fractional shares of Kezar Life Sciences with INDmoney app.

What are the documents required to start investing in Kezar Life Sciences stocks?

To start investing in Kezar Life Sciences, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Kezar Life Sciences

Today’s highest price of Kezar Life Sciences (KZR) is $6.56.

Today’s lowest price of Kezar Life Sciences (KZR) is $6.33.

What is today's market capitalisation of Kezar Life Sciences

Today's market capitalisation of Kezar Life Sciences KZR is 47.9M

What is the 52 Week High and Low Range of Kezar Life Sciences

  • 52 Week High

    $11.35

  • 52 Week Low

    $5.20

What are the historical returns of Kezar Life Sciences?

  • 1 Month Returns

    -11.71%

  • 3 Months Returns

    3.42%

  • 1 Year Returns

    -32.19%

  • 5 Years Returns

    -84.6%

Who is the Chief Executive Officer (CEO) of Kezar Life Sciences

Dr. Christopher J. Kirk Ph.D. is the current Chief Executive Officer (CEO) of Kezar Life Sciences.